• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

AbbVie’s Cerevel deal hits an uncommon roadblock

cafead

Administrator
Staff member
  • cafead   Feb 21, 2024 at 11:12: AM
via A “second request” from the Federal Trade Commission could protract the timing of AbbVie’s proposed acquisition, which is slated to close around the middle of the year.

article source
 

<